Stockreport

Harpoon Therapeutics up 9% on launch of HPN217 study in multiple myeloma [Seeking Alpha]

Harpoon Therapeutics, Inc.  (HARP) 
Last harpoon therapeutics, inc. earnings: 3/12 04:05 pm Check Earnings Report
PDF Thinly traded micro cap Harpoon Therapeutics (HARP+8.6%announcementPhase 1/2 clinical trialThe estimated primary completion date is January 2024.The action triggers a $5 [Read more]